← All organizations

TransMolecular

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Aug 11, 2008

Acquired by Morphotek → Eisai → Sarepta Therapeutics on Mar 4, 2011

Timeline

1990s

Jul 1, 1996
TransMolecular— Founded

2010s

Mar 4, 2011
Morphotek— Acquired By
Jan 1, 2014
Sarepta Therapeutics— Now

Drugs by trial phase (1 distinct, 6 trials)

Phase 2 (1 own, 0 via acquisition)

131i-tm-601

Indications

Studied for

Recent trials (7)

NCT00733798Lead sponsorPhase 1/Phase 2Aug 11, 2008
NCT00683761Lead sponsorPhase 1/Phase 2Aug 1, 2008
NCT00591058Lead sponsorPhase 1Feb 1, 2008
NCT00379132Lead sponsorPhase 1Aug 1, 2006
NCT00114309Lead sponsorPhase 2Nov 1, 2004
NCT00040573Study directorPhase 1/Phase 2Jun 1, 2002
NCT00040573Lead sponsorPhase 1/Phase 2Jun 1, 2002

Details

Founded: Birmingham, AL, US Jul 1, 1996
Last known activity: Aug 11, 2008